Thank you, Mr. Chairman.
This may not be the question for these witnesses, but I think it's a question that has to be considered. Looking at the extent of the metal fatigue with respect to the reactor, the scenario might be that the ability to repair this in the short term will prevent the meeting of the domestic isotope requirements from a health care perspective. We are told that 100% of the isotopes from this reactor go outside the country and 10% come back. Someone has to look at the technical capacity to take the McMaster reactor and the domestic concern to be served first. And that 10% in the shorter term.... I'm not talking about our international strategy and future marketing and so on, but meeting the needs of Canadians in the shorter term. It comes after Mr. Trost's question about giving help to others. Could AECL ramp up that technology, or are there shortcomings in that reactor similar to the NRU? Could we go into a strategy in the shorter term to meet our 10% domestic requirement by ramping up the McMaster reactor?